Is Pharmacy Ownership for You? +4 Points to Consider
PioneerRx
JANUARY 30, 2024
There are many ladders to climb in the pharmacy industry. Clerks can become techs, techs can be lead techs, and lead techs can be pharmacists.
PioneerRx
JANUARY 30, 2024
There are many ladders to climb in the pharmacy industry. Clerks can become techs, techs can be lead techs, and lead techs can be pharmacists.
STAT
FEBRUARY 1, 2024
New data released Thursday by the Centers for Disease Control and Prevention suggest that the most recent Covid-19 booster offers about 54% percent protection against infection with the virus. A study published in the CDC’s online journal Morbidity and Mortality Weekly Report showed that the updated vaccine was essentially equally effective at protecting against the strain targeted by the vaccine — called XBB.1.5 — and the JN.1 subvariant, which emerged after the vaccin
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaVoice
JANUARY 31, 2024
The president of L.A.’s City of Hope Cancer Center believes the current state of cancer treatments can be greatly improved with a peek into the gut’s many mysteries.
BioPharma Dive
JANUARY 30, 2024
Since a landmark paper in 2022, drugmakers have begun nearly a dozen trials of cell therapies for lupus, with more set to start. Here’s why their efforts are worth watching.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmaceutical Technology
JANUARY 29, 2024
At the JP Morgan Healthcare conference, Merck (MSD) indicated its eagerness to continue to establish its place in the immunological space.
STAT
JANUARY 29, 2024
LONDON — There was something odd about these Alzheimer’s cases. Part of it was the patients’ presentations: Some didn’t have the classic symptoms of the condition. But it was also that the patients were in their 40s and 50s, even their 30s, far younger than people who normally develop the disease. They didn’t even have the known genetic mutations that can set people on the course for such early-onset Alzheimer’s.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
The Pharmacist
FEBRUARY 1, 2024
Independent community pharmacies across the UK will begin offering private Covid vaccinations this spring, services provider Pharmadoctor has announced. For pharmacies that sign up for Pharmadoctor’s a patient group direction (PGD) package from today, the Nuvaxovid XBB.1.5 dispersion for injection vaccines will be available by 1 April 'at the latest', the company said today.
pharmaphorum
JANUARY 31, 2024
In this exclusive interview, Gene Kinney, CEO of Prothena, discusses the latest developments in the field of neurodegenerative diseases such as Alzheimer's and Parkinson's. Gain insights and advancements being made in the treatment of these conditions.
STAT
JANUARY 29, 2024
On Thursday evening, the state of Alabama executed Kenneth Eugene Smith by nitrogen gas. Now, there are dueling narratives about what happened. Alabama claims it went perfectly, proving that nitrogen is a humane, effective alternative to lethal injection (which it previously tried, unsuccessfully, to use on Smith). It says that based on this experience, other states should follow its example.
PharmaVoice
JANUARY 29, 2024
In addition to the chronic disease, the non-opioid drug may have applications in other painful conditions.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
The Pharmacist
FEBRUARY 1, 2024
Dr Alison Cave, chief safety officer at the Medicines and Healthcare products Regulatory Agency (MHRA), asks healthcare professionals to work together to better protect patients from the unnecessary harms of valproate, and to prescribe safer alternatives. New guidance was launched on 31 January The teratogenic effects of valproate, prescribed in the UK to treat epilepsy […] The post Work together to implement new safety measures for valproate appeared first on The Pharmacist.
BioPharma Dive
JANUARY 29, 2024
The FDA is reviewing the companies’ application for a “tumor agnostic” indication for their drug Enhertu, which would break new ground for antibody-drug conjugates.
STAT
FEBRUARY 2, 2024
Apple Vision Pro, the company’s most important new product in a decade, promises to envelop consumers in an immersive world of interactive content while employing clever technologies to make the device more usable and less alienating than virtual reality headsets that have come before it. Marketing for Vision Pro has focused on the $3,499, 1.3-pound helmet’s potential for watching video, making work calls, viewing family photos, and other casual uses.
Pharmaceutical Commerce
FEBRUARY 2, 2024
A dive into this market reveals that the latest numbers yield promising results—a global value of a worldwide $1.6 trillion—but it will continue to be attributed to past, present, and future healthcare spending.
The Pharmacist
JANUARY 30, 2024
A total of 10,265 community pharmacies in England will begin offering the new Pharmacy First service from today – marking what has been described as a ‘step-change’ for pharmacies, patients and the public. Among leaders welcoming the new service today is Prime Minister Rishi Sunak who said that with the launch of Pharmacy First the […] The post Over 10,000 pharmacies in England offering Pharmacy First from today appeared first on The Pharmacist.
BioPharma Dive
JANUARY 30, 2024
The company plans to soon ask the FDA for approval of the drug, which it has pitched as a safer alternative to addictive opioid painkillers.
STAT
FEBRUARY 2, 2024
Amid ongoing uncertainty about when abortions are permissible in Texas, the state’s medical board is under growing pressure to issue guidance on what type of emergency qualifies for an exemption from the state’s abortion ban. Two high-profile abortion supporters filed a petition in January requesting the board define what would be grounds for a legal abortion, and their efforts are backed by activists from across the political divide.
pharmaphorum
JANUARY 29, 2024
Creating a positive onboarding experience is crucial for engaging healthcare professionals (HCPs) in digital platforms and utilising data effectively. Discover why first impressions matter and how to get your onboarding process right for optimal digital engagement.
Pharmafile
JANUARY 30, 2024
Gracell Biotechnologies has announced that the US Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application, which allows them to initiate a phase 1 trial of GC012F in the US for the early-line treatment of multiple myeloma (ELMM). GC012F is “an autologous CAR T therapeutic candidate dual-targeting B cell maturation antigen […] The post FDA clears IND for Gracell Biotechnologies’ phase 1 clinical trial for multiple myeloma treatment appeared first on Pha
The Pharmacist
FEBRUARY 1, 2024
The Royal Pharmaceutical Society (RPS) has changed its stance on the separation of prescribing and dispensing, now accepting that both can be done by the same healthcare professional. The RPS said its new position had been formulated in response to changing practices in healthcare. The society’s previous guidance had emphasised the need for separation of […] The post RPS changes position on prescribing and dispensing separation appeared first on The Pharmacist.
STAT
JANUARY 31, 2024
The descent into dementia can feel like traversing a minefield, coming across new symptoms without the hope of a cure. But some dementia patients, even up to 10% of people diagnosed with the condition, might actually have undiagnosed liver disease and accompanying neurological problems, a new study in JAMA Open Network suggests. Most importantly, it’s possible their liver-related brain symptoms could be resolved with treatment.
pharmaphorum
FEBRUARY 1, 2024
Explore the current state of pharmaceutical meetings and events in 2024, including the shift from in-person to virtual and hybrid formats. Discover how the industry is embracing diversity, equity, and inclusion in these gatherings.
Drug Patent Watch
JANUARY 30, 2024
The recent paper published in PLOS ONE presents a novel approach for efficiently retrieving a substantial number of patents related to specific technologies. The authors enhance an automated patent landscaping… The post Revolutionizing Patent Landscaping: A Human-Supervised AI Approach to Identify Tech Clusters appeared first on DrugPatentWatch - Make Better Decisions.
The Pharmacist
JANUARY 31, 2024
The importance of publicising Pharmacy First has been underlined by a new survey showing that just under half (44%) of patients were unaware of the service which launches today. The poll, held by pharmacy platform Charac in partnership with YouGov, also found that only 23% of patients are currently using pharmacies as their initial port […] The post Public awareness poll highlights value of Pharmacy First promotion appeared first on The Pharmacist.
STAT
FEBRUARY 1, 2024
Researchers have long known that women are more likely to develop autoimmune disorders than men, though they’ve struggled to fully understand why. Now a new study in mice suggests a key part of the answer may be that an RNA molecule that’s indispensable for female survival steers the body toward immune friendly fire. A team led by Stanford scientists found that Xist, a molecule that teams up with proteins to keep female cells from activating a double (and deadly) dose of X chromoso
pharmaphorum
JANUARY 30, 2024
From today, a new feature added to the NHS App used in the UK will allow millions of people to submit and view prescriptions, in a bid to save time for patients and doctors. The digital prescription function, which does away with the need for paper scrip, was put through its paces in a pilot trial last year involving a million users of the app, now being used by three-quarters of the UK population or around 33.5 million people.
Pharmaceutical Commerce
JANUARY 29, 2024
In an interview with Pharma Commerce Associate Editor Don Tracy, Ron Lanton, Partner, Lanton Law PLLC, discusses recent moves by CVS and Express Scripts to follow Mark Cuban's drug plus model.
Express Pharma
FEBRUARY 1, 2024
Overall, the Union Budget 2024 reflects a forward-looking approach OPPI commends the Government’s approach towards the healthcare and pharmaceutical sector in the Union Budget 2024. The emphasis on leveraging existing hospital infrastructure for establishing new medical colleges is a strategic move that aligns with the need for a robust healthcare workforce.
STAT
JANUARY 30, 2024
Ultima Genomics, an upstart some observers have called a “ dark horse ” in the world of DNA sequencing, will soon launch a line of high-power instruments that can read a human genome for as little as $100, the company’s leadership told STAT. The sequencer, dubbed the UG 100, is a $1.5 million machine that can read up to 20,000 human genomes a year.
pharmaphorum
FEBRUARY 1, 2024
A phase 2 trial of Lundbeck’s alpha-synuclein-targeting drug Lu AF82422 has failed to reach statistical significance in patients with multiple system atrophy (MSA), although the company says there are encouraging “signals of efficacy” in the data.
The Pharmacist
FEBRUARY 2, 2024
Pharmacy minister Dame Andrea Leadsom has faced criticism from the sector after she claimed that allowing community pharmacists to alter prescriptions and supply alternative medications could ‘exacerbate’ supply issues. Individual pharmacists would be operating ‘without the full oversight of supply issues that the [Department of Health and Social Care] has’, she suggested.
BioPharma Dive
JANUARY 30, 2024
Roche, Pfizer and Bristol Myers Squibb have all invested in the startup, which is using nanoparticle technology to retrain the body’s immune system.
STAT
FEBRUARY 2, 2024
The Food and Drug Administration should move more quickly to ensure pulse oximeters — the ubiquitous devices used to measure blood oxygen — work well in all patients, should better inform clinicians about the devices’ shortcomings in patients with darker skin, and should recall versions that are particularly problematic, patients, researchers, and consumer advocates testified during a public meeting on Friday.
pharmaphorum
FEBRUARY 1, 2024
On today's podcast, brought to you by Kadans Science Partners, host Jonah Comstock is joined by Bradley Hardiman, Astellas Pharma’s Senior Director of Business Development; Mike Murray, head of Murray International Partners Ltd; and Mairi Dillon, Kadans' Ecosystem Manager for UK & Ireland.
The Pharmacist
JANUARY 29, 2024
A series of resources to help pharmacists promote the incoming Pharmacy First service has been made available by Community Pharmacy England (CPE). The launch date for the new service has been confirmed as 31 January, and CPE emphasised that for its self-referral (walk-in) aspect to be a success, the general public and patients need to […] The post CPE stresses need for Pharmacy First awareness with publicity launch appeared first on The Pharmacist.
Let's personalize your content